Minzhi Xing

2.4k citations
87 papers · 1.7k indexed · h-index 24
Topics
Hepatocellular Carcinoma Treatment and Prognosis (38 papers)Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers)Renal cell carcinoma treatment (11 papers)

In The Last Decade

Minzhi Xing

85 papers receiving 1.7k citations

Peers

Minzhi Xing
Comparison fields: 5 of 102
  • Hepatology 603
  • Pulmonary and Respiratory Medicine 512
  • Surgery 494
  • Molecular Biology 434
  • Oncology 320
Replace Magnus Rizell with:
Magnus Rizell Sweden
Philippe Labrune France
Markus Rentsch Germany
Kuno Lehmann Switzerland
Allison F. O’Neill United States
Joost R.M. van der Sijp Netherlands
Thomas Lorf Germany
Olivier Lidove France
Shigetaka Sugihara Japan
Yee‐Min Jen Taiwan
Minzhi Xing relative to Magnus Rizell Sweden Magnus Rizell's profile →
Citations per field
00.5×1.5×1.9×
Magnus Rizell · 1×
Citations per year

Countries citing papers authored by Minzhi Xing

Since Specialization
Citations

This map shows the geographic impact of Minzhi Xing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minzhi Xing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minzhi Xing more than expected).

Fields of papers citing papers by Minzhi Xing

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minzhi Xing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minzhi Xing. The network helps show where Minzhi Xing may publish in the future.

Co-authorship network of co-authors of Minzhi Xing

This figure shows the co-authorship network connecting the top 25 collaborators of Minzhi Xing. A scholar is included among the top collaborators of Minzhi Xing based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minzhi Xing. Minzhi Xing is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 3
3 2
4 14
5 8
6 16
7 20
8 14
9 21
10 77
11 4
12 8
13 11
14 12
15 2
16 58
17 39
18 81
19 40
20 77

About Minzhi Xing

Minzhi Xing is a scholar working on Hepatology, Biological Psychiatry and Pulmonary and Respiratory Medicine, having authored 87 papers that have together received 1.7k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (38 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Renal cell carcinoma treatment (11 papers). The work is most often cited by research in Hepatology (603 citations), Physiology (77 citations) and Pulmonary and Respiratory Medicine (512 citations). Minzhi Xing has collaborated with scholars based in United States, China and Australia. Frequent co-authors include Hyun S. Kim, Nima Kokabi, Juan C. Camacho, Paul A. Insel, Rafael Mattera, Johannes Ludwig, Rengyun Liu, Bassel F. El‐Rayes, Hasmukh J. Prajapati and Pardeep Mittal. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026